Pular para o conteúdo
Merck
  • Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.

Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2017-06-20)
Arik Dahan, Milica Markovic, Svetlana Epstein, Noa Cohen, Ellen M Zimmermann, Aaron Aponick, Shimon Ben-Shabat
RESUMO

The enzyme phospholipase A

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
DL-2-Aminocaprylic acid, 99%